Skip to navigation menu Skip to content
Illustration of a calendarIllustration of a document pageIllustration of a heart over a handIllustration of an envelopeIllustration of the letter i inside a circleIllustration of a map markerIllustration of a caduceusIllustration of a user with a plus signIllustration of a telephoneIllustration of a question mark inside a circleIllustration of a video cameraDocument with a PDF label
Clinical Trial Search block Test

A randomized trial of low versus moderate exposure busulfan for infants with severe combined immunodeficiency (SCID) receiving TCRaß+/CD19+ depleted transplantation: A Phase II study by the Primary Immune Deficiency Treatment Consortium (PIDTC) and Pediatric Blood and Marrow Transplant Consortium (PBMTC) PIDTC ?CSIDE? Protocol (Conditioning SCID Infants Diagnosed Early) PBMTC NMD 1801

8731 C-SIDE

  • Condition(s): Other Hematopoietic
  • Clinicaltrials.gov ID: NCT03619551

What is the goal of the study?

To learn more about this study, please email the study team member listed below.

Who can participate in the study?

Everyone

Study Team: